Gemcitabine plus nab-paclitaxel or gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: A population-based, multicenter AGEO study

被引：1
|
作者：
Zaibet, S. [1 ]
Hautefeuille, V. [2 ]
Auclin, E. [1 ]
Lievre, A. [3 ]
Tougeron, D. [4 ,5 ]
Sarabi, M. [6 ]
Gilabert, M. [7 ]
Wasselin, J.
Edeline, J. [8 ]
Artru, P. [9 ]
Bechade, D. [10 ]
Morin, C. [6 ]
Taieb, J. [11 ]
Pernot, S. [10 ]
机构：
[1] AP HP, Paris, France
[2] CHU Amiens, Amiens, France
[3] CHU Rennes, Rennes, France
[4] Univ Poitiers Hosp, Gastroenterol Dept, Poitiers, France
[5] Univ Poitiers, Poitiers, France
[6] Ctr Leon Berard, Lyon, France
[7] Inst Paoli Calmettes, Marseille, France
[8] Ctr Eugene Marquis, Rennes, France
[9] Hop Prive Jean Mermoz, Lyon, France
[10] Inst Bergonie, Bordeaux, France
[11] Paris Descartes Univ, Georges Pompidou European Hosp, Sorbonne Paris Cite, Paris, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.462
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-6
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [1] Gemcitabine plus Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Zaibet, Simon
    Hautefeuille, Vincent
    Auclin, Edouard
    Lievre, Astrid
    Tougeron, David
    Sarabi, Mathieu
    Gilabert, Marine
    Wasselin, Julie
    Edeline, Julien
    Artru, Pascal
    Bechade, Dominique
    Morin, Clemence
    Ducoulombier, Agnes
    Taieb, Julien
    Pernot, Simon
    BRITISH JOURNAL OF CANCER, 2022, 126 (10) : 1394 - 1400
  • [2] Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Sonia Zaibet
    Vincent Hautefeuille
    Edouard Auclin
    Astrid Lièvre
    David Tougeron
    Mathieu Sarabi
    Marine Gilabert
    Julie Wasselin
    Julien Edeline
    Pascal Artru
    Dominique Bechade
    Clémence Morin
    Agnes Ducoulombier
    Julien Taieb
    Simon Pernot
    British Journal of Cancer, 2022, 126 : 1394 - 1400
  • [3] Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Sonia Zaibet
    Vincent Hautefeuille
    Edouard Auclin
    Astrid Lièvre
    David Tougeron
    Mathieu Sarabi
    Marine Gilabert
    Julie Wasselin
    Julien Edeline
    Pascal Artru
    Dominique Bechade
    Clémence Morin
    Agnes Ducoulombier
    Julien Taieb
    Simon Pernot
    British Journal of Cancer, 2022, 126 : 969 - 969
  • [4] Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
    Portal, Alix
    Pernot, Simon
    Tougeron, David
    Arbaud, Claire
    Bidault, Anne Thirot
    de la Fouchardiere, Christelle
    Hammel, Pascal
    Lecomte, Thierry
    Dreanic, Johann
    Coriat, Romain
    Bachet, Jean-Baptiste
    Dubreuil, Olivier
    Marthey, Lysiane
    Dahan, Laetitia
    Tchoundjeu, Belinda
    Locher, Christophe
    Lepere, Celine
    Bonnetain, Franck
    Taieb, Julien
    BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 989 - 995
  • [5] Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
    Alix Portal
    Simon Pernot
    David Tougeron
    Claire Arbaud
    Anne Thirot Bidault
    Christelle de la Fouchardière
    Pascal Hammel
    Thierry Lecomte
    Johann Dréanic
    Romain Coriat
    Jean-Baptiste Bachet
    Olivier Dubreuil
    Lysiane Marthey
    Laetitia Dahan
    Belinda Tchoundjeu
    Christophe Locher
    Céline Lepère
    Franck Bonnetain
    Julien Taieb
    British Journal of Cancer, 2015, 113 : 989 - 995
  • [6] Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
    Caterina Vivaldi
    Lorenzo Fornaro
    Chiara Caparello
    Alfredo Falcone
    Enrico Vasile
    British Journal of Cancer, 2016, 114 : e8 - e8
  • [7] Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
    Vivaldi, Caterina
    Fornaro, Lorenzo
    Caparello, Chiara
    Falcone, Alfredo
    Vasile, Enrico
    BRITISH JOURNAL OF CANCER, 2016, 114 (11) : e8 - e8
  • [8] Nab paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after failure of folfirinox: Results of an AGEO multicenter prospective cohort
    Portal, Alix
    Pernot, Simon
    Arbaud, Claire
    Tougeron, David
    Thirot-Bidault, Anne
    De La Fouchardiere, Christelle
    Hammel, Pascal
    Lecomte, Thierry
    Dreanic, Johann
    Coriat, Romain
    Bachet, Jean Baptiste
    Dubreuil, Olivier
    Marthey, Lysiane
    Dahan, Laetitia
    Legoux, Jean-Louis
    Locher, Christophe
    Lepere, Celine
    Rougier, Philippe
    Bonnetain, Franck
    Taieb, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.
    Ozaka, Masato
    Sasaki, Takashi
    Kataoka, Seita
    Kanata, Ryo
    Ishigaki, Kazunaga
    Yamada, Ikuhiro
    Matsuyama, Masato
    Takano, Koichi
    Sasahira, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [10] Reply to the comment on ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
    Simon Pernot
    Jean-Baptiste Bachet
    Alix Portal
    Julien Taieb
    British Journal of Cancer, 2016, 114 : e9 - e9
12345